About Archimedis
Archimedis is a Healthcare company based in Kanchipuram (India) founded in 2014. It serves as a CDMO specializing in solid drug formulation manufacturing. It operates on a B2B model. The company has 87 employees. Its Indian entity Archimedis Digital Private Limited reported revenue of ₹28.35 Cr. Its focus areas include Pharmaceuticals, Manufacturing and Drug Formulation. Its competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Archimedis serves as a cdmo specializing in solid drug formulation manufacturing through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug formulation. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Kanchipuram, India
- Employees 87
- SectorsHealthcare
- Website archimedis.global
- Legal Name Archimedis Digital Private Limited
- Date of Incorporation 31 May, 2022
- Annual Revenue₹28.35 Cr
FY 2025 · +33% YoY
- Net Profit₹9.89 Cr
FY 2025 · 35% margin
- EBITDA₹12.69 Cr
FY 2025 · 45% margin
- Employee Count87
Associated legal entities of Archimedis
Archimedis operates through Archimedis Digital Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Archimedis Digital Private Limited CIN U72900TN2022PTC152741 | Active | 31 May 2022 | Chennai, Tamil Nadu | ₹28.4 Cr | 68 | 2 | View details |
Board of directors of Archimedis Digital Private Limited (Archimedis)
Archimedis Digital Private Limited is the primary company behind Archimedis. The board of Archimedis Digital Private Limited currently have 2 directors; the longest-serving is Duraisamy Rajan Palani, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Duraisamy Rajan Palani DIN 06864625 | Director | 31 May 2022 | 4 yrs 5 mo | Archimedis Digital Private Limited |
| Leena Narayanan Kulakkunnath DIN 09626230 | Director | 31 May 2022 | 4 yrs 5 mo | Archimedis Digital Private Limited |
Financials of Archimedis
Figures of Archimedis Digital Private Limited, the primary company behind Archimedis, for FY 2025. Revenue was ₹28.35 Cr (+33% year on year). Net profit was ₹9.89 Cr (35% margin). EBITDA was ₹12.69 Cr (45% margin).
- ₹28.35 CrRevenue · FY 2025 · +33% YoY
- ₹9.89 CrNet profit · 35% margin
- ₹12.69 CrEBITDA · 45% margin
- ₹90,000Paid-up capital
- 68Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Archimedis Digital Private Limited are on its company page.
Detailed financial statements for Archimedis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Archimedis
Archimedis has 3 listed competitors in our database, 2 of them funded. They include Inventia Healthcare, Zim Labs and Halewood Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inventiahealthcare.com | 1985 | Mumbai, India | $42.49M | 980 | Oral solid drug delivery systems are manufactured and developed. | |
| zimlab.in | 1989 | Nagpur, India | $8.2M | 598 | Solid and semisolid dosage forms are developed and manufactured. | |
| halewoodlabs.com | 1984 | Ahmedabad, India | 348 | Provides contract manufacturing services for food, pharmaceuticals, and related products globally. |
Detailed competitors of Archimedis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Archimedis
Complete news archive for Archimedis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Archimedis
Archimedis was founded in 2014.
Archimedis is headquartered in Kanchipuram, India. It is registered at Kanchipuram, Tamil Nadu, India.
Archimedis has 87 employees.
The primary company behind Archimedis, Archimedis Digital Private Limited, reported revenue of ₹28.35 Cr for FY 2025, up 33% year on year.
Archimedis serves as a cdmo specializing in solid drug formulation manufacturing through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug formulation. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Archimedis's top competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories.
Archimedis operates through Archimedis Digital Private Limited.
The legal entities of Archimedis currently have 2 directors, including Duraisamy Rajan Palani, Leena Narayanan Kulakkunnath.